M&A

New Details Emerge in Johnson & Johnson's Pursuit of Actelion
Motley Fool
Tue, 01/3/17 - 05:23 pm
JNJ
Actelion
M&A
Sanofi
Trump Tax Holiday May Fuel Drug M&A Boom
Investopedia
Tue, 01/3/17 - 12:01 pm
Donald Trump
taxes
M&A
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi
Fake News? Valeant May Crash On Tuesday
Seeking Alpha
Mon, 01/2/17 - 04:21 pm
Valeant Pharmaceuticals
M&A
Takeda
Abbott Sets Closing Date for St. Jude Medical Deal
Investopedia
Sun, 01/1/17 - 12:04 pm
Abbott Labs
St. Jude Medical
M&A
devices
Sanofi-Biogen Merger Could Deliver Potential Synergies
Seeking Alpha
Sun, 01/1/17 - 11:32 am
Sanofi
Biogen
M&A
Are J&J and Actelion Getting Closer
Investopedia
Sun, 01/1/17 - 11:31 am
JNJ
Actelion
M&A
Holding out for a pharma M&A rebound in 2017? It may be a while
Fierce Pharma
Wed, 12/28/16 - 11:23 am
M&A
Abbott Laboratories: More Insiders Buy As Acquisition Uncertainties Likely To Clear
Seeking Alpha
Wed, 12/28/16 - 11:07 am
Abbott Labs
M&A
St. Jude Medical
devices
The Most Likely Incyte Acquisition Deal for 2017?
Motley Fool
Sat, 12/24/16 - 12:11 pm
M&A
Incyte
Gilead Sciences
Lilly
Novartis
Agenus
[video]J&J-Actelion Talks Resume: What’s Next for Sanofi?
Bloomberg
Fri, 12/23/16 - 10:05 am
JNJ
Actelion
Sanofi
M&A
Japanese pharma snaps up cancer biotech Tolero
BioPharma Dive
Fri, 12/23/16 - 10:03 am
Japan
Tolero Pharmaceuticals
M&A
Sumitomo Dainippon
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Yahoo
Fri, 12/23/16 - 10:00 am
Pfizer
M&A
AstraZeneca
small molecule drugs
anti-infectives
Make that two biotech reverse mergers in one day
Endpoints
Fri, 12/23/16 - 09:55 am
biotech
M&A
Tokai
Otic
Dipexium Pharmaceuticals
PLx Pharma
[video]Actelion and J&J Circle Back to Negotiating Table
Bloomberg
Thu, 12/22/16 - 11:41 am
Actelion
JNJ
M&A
Sanofi
Actelion shares gain on report of progress in Sanofi talks
Yahoo/Reuters
Wed, 12/21/16 - 11:14 am
Actelion
M&A
Sanofi
Investors see Biogen CEO choice as friendly to potential takeover
Yahoo/Reuters
Wed, 12/21/16 - 11:12 am
Biogen
Pharma CEOs
M&A
Michel Vounatsos
Can Sanofi push a CVR on Actelion after the Lemtrada fiasco?
Endpoints
Wed, 12/21/16 - 10:54 am
Sanofi
CVRs
Actelion
Lemtrada
M&A
Sanofi's takeover talks with Actelion progressing - source
Yahoo/Reuters
Wed, 12/21/16 - 10:49 am
Sanofi
M&A
Actelion
Allergan picks up regenerative med company for $2.9B
BioPharma Dive
Wed, 12/21/16 - 10:47 am
Allergan
M&A
regenerative medicine
Acelity
devices

Pages